首页 | 官方网站   微博 | 高级检索  
     

基于SMD-TCM证据库生成益气活血类中成药治疗冠心病心绞痛的系统评价再评价
引用本文:季昭臣,胡海殷,李楠,王可仪,王虎城,张明妍,李凯,王辉,刘春香,郑文科,张俊华. 基于SMD-TCM证据库生成益气活血类中成药治疗冠心病心绞痛的系统评价再评价[J]. 天津中医药, 2021, 38(6): 745-750
作者姓名:季昭臣  胡海殷  李楠  王可仪  王虎城  张明妍  李凯  王辉  刘春香  郑文科  张俊华
作者单位:天津中医药大学循证医学中心, 天津 301617
基金项目:国家自然科学基金项目(81473544);天津市人才发展特殊支持计划-青年拔尖人才项目(201504)。
摘    要:[目的]基于中医药系统评价/Meta分析证据库(SMD-TCM),对口服益气活血类中成药治疗冠心病心绞痛的系统评价/Meta分析进行再评价,并验证SMD-TCM各部分功能.[方法]计算机检索SMD-TCM,获取并筛选文献,借助SMD-TCM对口服益气活血类中成药治疗冠心病心绞痛的系统评价/Meta分析进行再评价.[结果...

关 键 词:益气活血  中成药  冠心病  心绞痛  系统评价  Meta分析  再评价
收稿时间:2021-01-05

Yiqi Huoxue Chinese patent medicine for coronary heart disease with angina pectoris: an overview based the systematic review/Meta-analysis database of traditional Chinese medicine
JI Zhaochen,HU Haiyin,LI Nan,WANG Keyi,WANG Hucheng,ZHANG Mingyan,LI Kai,WANG Hui,LIU Chunxiang,ZHENG Wenke,ZHANG Junhua. Yiqi Huoxue Chinese patent medicine for coronary heart disease with angina pectoris: an overview based the systematic review/Meta-analysis database of traditional Chinese medicine[J]. Tianjin Journal of Traditional Chin Medicine, 2021, 38(6): 745-750
Authors:JI Zhaochen  HU Haiyin  LI Nan  WANG Keyi  WANG Hucheng  ZHANG Mingyan  LI Kai  WANG Hui  LIU Chunxiang  ZHENG Wenke  ZHANG Junhua
Affiliation:Evidence-based Medicine Center, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China
Abstract:[Objective] Base on the systematic review/Meta-analysis database of traditional Chinese medicine (SMD-TCM),the systematic review/meta-analysis of Yiqi Huoxue oral Chinese patent medicine for coronary heart disease with angina pectoris was overviewed,and to check the function of the SMD-TCM.[Methods] The systematic review/meta-analysis of Yiqi Huoxue oral Chinese patent medicine for coronary heart disease with angina pectoris was searched and overviewed by the SMD-TCM.[Results] Finally, 26 systematic review/Meta-analysis of yiqi huoxue oral Chinese patent medicine for coronary heart disease with angina pectoris were included. Evaluation results showed:All the included studies reported the efficacy of yiqi huoxue oral Chinese patent medicine in the treatment of coronary heart disease with angina pectoris. Safety reports were made in 19 studies,while 7 were not reported,and there were some problems such as unclear report,no group distinction and no reported number of patients. In terms of methodological quality and reporting standards,there are some deficiencies in the included studies,which need to be improved.[Conclusion] All functions of the SMD-TCM are running normally,which greatly reduces the time for overview,improves the efficiency of research,and saves time and human cost.
Keywords:yiqi huoxue  Chinese patent medicine  coronary heart disease  angina pectoris  systematic review  Meta-analysis  overview
点击此处可从《天津中医药》浏览原始摘要信息
点击此处可从《天津中医药》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号